Regulatory15 May 2026, 06:51 pm
Kilitch Drugs: Monitoring Report for Quarter Ended March 2026
AI Summary
Kilitch Drugs India Ltd has submitted the monitoring agency report for the quarter ended March 31, 2026, in compliance with SEBI regulations. The report, dated May 15, 2026, was issued by Infomerics Valuation and Rating Limited. The report indicates no deviation from the objects of the issue, though ₹1.12 crore remains unutilized from the GCP facility, expected to be utilized in Q1FY27 due to pending capex-related payments and final inspection.
Key Highlights
- Kilitch Drugs submits monitoring agency report for Q4 2026.
- Report by Infomerics Valuation indicates no deviation from issue objectives.
- ₹1.12 crore from GCP facility remains unutilized, expected in Q1FY27.
- Utilization delayed due to pending capex payments and final inspection.
Price Impact
More from KILITCH